Breaking News, Financial News

1Q Financial Report: West Pharmaceutical Services

1Q Revenues: $222.8 million (+49%)

1Q Earnings: $18.1 million (+36%)

Comments: Revenues were positively impacted by a number of acquisitions made during 2005, including Monarch Analytical Laboratories and Medimop Medical Projects. The Pharmaceutical Systems segment grew 18.5% to $160 million. “Product line strength continues in coated versions of prefilled syringe components and serum vial stoppers and products employing the Company’s Westar post-production processes,” according to the company.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters